Showing 1,761 - 1,780 results of 1,866 for search '"spondylitis"', query time: 0.10s Refine Results
  1. 1761

    T cell phenotype and function in Spondyloarthritis by Ridley, AL

    Published 2013
    “…<p>Th17 cells are implicated in a variety of inflammatory disorders including Spondyloarthritis (SpA). Ankylosing spondylitis (AS), the most common SpA, is genetically associated with HLA-B27 and IL-23R polymorphisms, although the link remains unexplained. …”
    Thesis
  2. 1762

    Critical role of endoplasmic reticulum aminopeptidase 1 in determining the length and sequence of peptides bound and presented by HLA-B27. by Chen, L, Fischer, R, Peng, Y, Reeves, E, McHugh, K, Ternette, N, Hanke, T, Dong, T, Elliott, T, Shastri, N, Kollnberger, S, James, E, Kessler, B, Bowness, P

    Published 2014
    “…OBJECTIVE: HLA-B27 and endoplasmic reticulum aminopeptidase 1 (ERAP1) are the two strongest genetic factors predisposing to ankylosing spondylitis (AS). A key aminopeptidase in class I major histocompatibility complex presentation, ERAP1 potentially contributes to the pathogenesis of AS by altering HLA-B27 peptide presentation. …”
    Journal article
  3. 1763

    Clinical phenotype is related to HLA genotype in the peripheral arthropathies of inflammatory bowel disease. by Orchard, T, Thiyagaraja, S, Welsh, K, Wordsworth, B, Hill Gaston, J, Jewell, D

    Published 2000
    “…The results were compared with those of a cohort of 30 patients with postenteric reactive arthritis (ReA) and 16 patients with IBD-associated ankylosing spondylitis (IBD-AS). RESULTS: Type 1 arthropathy was associated with HLA-DRB1*0103 (DR103; a rare subtype of DR1) in 33% (P &lt; 0.0001; relative risk [RR], 12.1), B*35 in 30% (P = 0.01; RR, 2.2), and B*27 in 26% (P = 0. 001; RR, 4.0). …”
    Journal article
  4. 1764

    Results of a global, patient-based survey assessing the impact of psoriatic arthritis discussed in the context of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire by Coates, LC, Orbai, A-M, Azevedo, VF, Cappelleri, JC, Steinberg, K, Lippe, R, Lim, I, Eder, L, Richette, P, Weng, MY, Queiro Silva, R, Fallon, L

    Published 2020
    “…<p><strong>Background:</strong> Psoriatic arthritis (PsA) is a chronic immune-mediated inflammatory musculoskeletal disease, manifesting as peripheral arthritis, enthesitis, dactylitis, spondylitis, and skin and nail psoriasis. A core set of domains for measuring the impact of PsA has been developed, including pain, patient global assessment, physical function, health-related quality of life (HRQoL), and fatigue. …”
    Journal article
  5. 1765

    Endoplasmic reticulum aminopeptidase 1 (ERAP1) plays a critical role in determining the length and sequence of peptides bound and presented by HLA-B27 by Chen, L, Fischer, R, Peng, Y, Reeves, E, McHugh, K, Ternette, N, Hanke, T, Dong, T, Elliott, T, Shastri, N, Kollnberger, S, James, E, Bowness, P

    Published 2013
    “…</strong> HLA-B27 and ERAP1 are the two strongest predisposing genetic factors to Ankylosing Spondylitis (AS). A key aminopeptidase in MHC class I presentation, ERAP1 potentially contributes to AS pathogenesis through altering HLA-B27 peptide presentation. …”
    Journal article
  6. 1766

    Epidemiology of low back pain: frequency, risk factors, and patterns in South-South Nigeria by Airenakho Emorinken, Cyril Oshomah Erameh, Blessyn Omoye Akpasubi, Mercy Ofunami Dic-Ijiewere, Asuwemhe Johnson Ugheoke

    Published 2023-10-01
    “…Common etiologies were spondylosis (66.5%), spondylolisthesis (22.3%), disc prolapse (19.4%), spinal canal stenosis (15.4%), muscle spasm (12.2%), and tuberculous spondylitis (9.7%). Acute and chronic LBP constituted 12.2% and 79.9% of cases, respectively. …”
    Get full text
    Article
  7. 1767

    ANTI-HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN B1 (ANTI-RA33) ANTIBODIES IN RHEUMATOID ARTHRITIS AND SYSTEMIC SCLEROSIS by P. A. Kuznetsova, A. L. Maslyansky, S. V. Lapin, O. Yu. Tkachenko, V. I. Mazurov

    Published 2017-04-01
    “…The authors studied the frequency of anti-RNP B1 AAbs in 300 patients with systemic ARDs, including those with rheumatoid arthritis (RA), ankylosing spondylitis (AS), systemic lupus erythematosus (SLE), systemic sclerosis (SSc), and Sjö gren's syndrome (SS) and in 53 people without ARDs, who constituted a control group. …”
    Get full text
    Article
  8. 1768

    Causal associations between common musculoskeletal disorders and dementia: a Mendelian randomization study by Jiachen Wang, Mingyi Yang, Ye Tian, Ruoyang Feng, Ke Xu, Menghao Teng, Junxiang Wang, Qi Wang, Peng Xu

    Published 2023-12-01
    “…Simultaneously, ankylosing spondylitis was an independent risk factor for dementia, dementia with Lewy bodies, and dementia in Alzheimer’s disease. …”
    Get full text
    Article
  9. 1769

    Efficacy and safety of ixekizumab treatment in patients with axial spondyloarthritis: 2-year results from COAST by Maxime Dougados, Atul Deodhar, Jürgen Braun, Uta Kiltz, Chen-Yen Lin, Tetsuya Tomita, Rebecca Bolce, Jessica Walsh, David Sandoval

    Published 2022-12-01
    “…The proportion of patients achieving Ankylosing Spondylitis Disease Activity Score &lt;2.1 through week 116 was 57.0% and 52.9% for bDMARD-naïve patients with r-axSpA and nr-axSpA, respectively, and 33.6% for TNFi-experienced patients. …”
    Get full text
    Article
  10. 1770

    Characteristic analysis of adverse reactions of five anti-TNFɑ agents: a descriptive analysis from WHO-VigiAccess by Mingming Li, Ruxu You, Yuyong Su, Hongbo Zhou, Shiwei Gong

    Published 2023-07-01
    “…Introduction: Tumor necrosis factor (TNF) inhibitors (adalimumab, infliximab, etanercept, golimumab, and certolizumab pegol) have revolutionized the treatment of severe immune-mediated inflammatory diseases, including rheumatoid arthritis, Crohn’s disease, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. This study assessed adverse drug reactions (ADRs) after the use of TNFα inhibitors in VigiAccess of the World Health Organization (WHO) and compared the adverse reaction characteristics of five inhibitors to select the drug with the least risk for individualized patient use.Methods: The study was a retrospective descriptive analysis method in design. …”
    Get full text
    Article
  11. 1771

    Assessment of PD-1 gene variation in patients with multiple sclerosis by Shadmehri AA, Nicknam MH, Shokrgozar MA, Mahmoudi M, Sarial Sh, Ahmadi Shadmehri A, Moradi B, Farhadi E, Amirzargar AA

    Published 2010-05-01
    “…This study was performed to investigate the role of polymorphisms of the programmed cell death 1 (PD-1) gene on susceptibility to ankylosing spondylitis. This gene codes an immunoreceptor named PD-1, which has a cytoplasmic domain containing two tyrosine residues located within immunoreceptor tyrosine-based inhibitory and switch motifs (ITIM and ITSM), suggesting that PD-1 is predominantly inhibitory which responsible for the negative regulation in T cell activation and peripheral tolerance. …”
    Get full text
    Article
  12. 1772

    Diagnostic Significance of the Level of Soluble Stimulating Growth Factor in Patients with Spondyloarthritis as an Early Marker of Cardiovascular Pathology by K. D. Dorogoykina, K. N. Safarova, E. A. Fedotov, A. P. Rebrov

    Published 2022-05-01
    “…A total of 46 patients aged 39.2 ± 10.2 years with SpA (including 40 (87 %) with ankylosing spondylitis, 6 (13 %) with psoriatic arthritis) were examined. …”
    Get full text
    Article
  13. 1773

    Evaluation of 55 Cases with Spondylodiscitis Due to Brucellosis by Servet KÖLGELİER, Nazlım AKTUĞ DEMİR, Aykut AKPINAR, Serap ÖZÇİMEN, Lütfi Saltuk DEMİR, Adem YILDIRIM, Şua SÜMER

    Published 2013-12-01
    “…In spinal brucellosis, first the vertebra corpus is involved, then spread to the neighboring disc space and vertebra corpus is observed, and with disc involvement, spondylitis evolves into spondylodiscitis. Brucellosis should be considered in the differential diagnosis in the presence of fever and lower back symptoms, especially in patients living in endemic regions.…”
    Get full text
    Article
  14. 1774

    Evaluation of active inflammation, chronic structural damage, and response to treatment of sacroiliitis in axial spondyloarthritis using the Spondyloarthritis research consortium o... by Yimeng Zhang, Zikang Guo, Ying Zhan, Jin Qu, Xinwei Lei

    Published 2022-07-01
    “…To investigate whether there are differences in inflammatory and chronic structural damages, as assessed by a semiquantitative MRI scoring method, between non-radiographic axial spondyloarthritis (nr-axSpA) and ankylosing spondylitis (AS) patients with active inflammation at baseline, and to evaluate the treatment response in these patients after 3 months of tumor necrosis factor-alpha (TNF-α) inhibitor treatment. …”
    Get full text
    Article
  15. 1775

    The Treatment with Interleukin 17 Inhibitors and Immune-Mediated Inflammatory Diseases by Laura Țiburcă, Marius Bembea, Dana Carmen Zaha, Alexandru Daniel Jurca, Cosmin Mihai Vesa, Ioana Adela Rațiu, Claudia Maria Jurca

    Published 2022-04-01
    “…Tough, clinical trials of IL-17i have described cases of exacerbation or even onset of inflammatory bowel disease (IBD), such as Crohn’s disease and ulcerative colitis, after administration of these drugs in patients previously diagnosed with psoriasis (PS), psoriatic arthritis (PsA), or ankylosing spondylitis (AS). The pathophysiological mechanism of action is not well understood at present. …”
    Get full text
    Article
  16. 1776

    Factors associated with discontinuation of biologics in patients with inflammatory arthritis in remission: data from the BIOBADASER registry by Marta Valero, Carlos Sánchez-Piedra, Mercedes Freire, María Colazo, Noemí Busquets, Erardo Meriño-Ibarra, Carlos Rodríguez-Lozano, Sara Manrique, Cristina Campos, Fernando Sánchez-Alonso, Isabel Castrejón

    Published 2023-05-01
    “…Methods An observational retrospective study from the BIOBADASER registry comprising adult patients diagnosed with rheumatoid arthritis (RA), ankylosing spondylitis (AS), or psoriatic arthritis (PsA) and receiving 1 or 2 biological disease-modifying drugs (bDMARDs) between October 1999 and April 2021. …”
    Get full text
    Article
  17. 1777

    Clinical Features of Human Brucellosis and Risk Factors for Focal Complications: A Retrospective Analysis in a Tertiary-Care Hospital in Beijing, China by Zhang Z, Zhang X, Chen X, Cui X, Cai M, Yang L, Zhang Y

    Published 2022-09-01
    “…Of all the patients, 76 (38.6%) were reported with focal complications, including 16 (8.1%) peripheral arthritis, 36 (18.3%) spondylitis, 17 (8.6%) epididymoorchitis, 8 (4.1%) meningitis and 3 (1.3%) endocarditis. …”
    Get full text
    Article
  18. 1778

    Prevalence of familial autoimmune diseases in juvenile idiopathic arthritis: results from the international Pharmachild registry by Joeri W. van Straalen, Sytze de Roock, Gabriella Giancane, Ekaterina Alexeeva, Elena Koskova, Pablo Mesa-del-Castillo Bermejo, Francesco Zulian, Adele Civino, Davide Montin, Nico M. Wulffraat, Nicolino Ruperto, Joost F. Swart, for the Paediatric Rheumatology International Trials Organisation (PRINTO)

    Published 2022-11-01
    “…Results Eight thousand six hundred seventy three patients were included and the most common familial ADs were psoriasis, autoimmune thyroid disease, rheumatoid arthritis and ankylosing spondylitis. The prevalence of several ADs was higher in parents of the included JIA patients than in the general population. …”
    Get full text
    Article
  19. 1779

    Clinical Application of Personalized Digital Surgical Planning and Precise Execution for Severe and Complex Adult Spinal Deformity Correction Utilizing 3D Printing Techniques by Hongtao Ding, Yong Hai, Lijin Zhou, Yuzeng Liu, Yiqi Zhang, Chaofan Han, Yangpu Zhang

    Published 2023-03-01
    “…The perioperative, and radiological parameters and complications, including surgery duration, estimated blood loss, pre- and post-operative cobb angle, trunk balance, and precision of osteotomy operation with screw implantation were collected retrospectively and analyzed to evaluate the clinical efficacy and safety of this technique. (3) Results: Of the eight patients, the primary pathology of scoliosis included two adult idiopathic scoliosis (ADIS), four congenital scoliosis (CS), one ankylosing spondylitis (AS), and one tuberculosis (TB). Two patients had a previous history of spinal surgery. …”
    Get full text
    Article
  20. 1780

    Multi‐omics integration reveals a core network involved in host defence and hyperkeratinization in psoriasis by Jingwen Deng, Emmerik Leijten, Michel Olde Nordkamp, Guangjuan Zheng, Juliëtte Pouw, Weiyang Tao, Sarita Hartgring, Deepak Balak, Rianne Rijken, Runyue Huang, Timothy Radstake, Chuanjian Lu, Aridaman Pandit

    Published 2022-12-01
    “…Methods We collected the skin tissue biopsies and swabs in both lesional and non‐lesional skin of 13 patients with psoriasis, 15 patients with psoriatic arthritis and healthy skin from 12 patients with ankylosing spondylitis. To study the similarities and differences in the molecular profiles between these three conditions, and the associations between the host defence and microbiota composition, we performed high‐throughput RNA‐sequencing to quantify the gene expression profile in tissues. …”
    Get full text
    Article